The MHRA has approved tisotumab vedotin for adults with recurrent or metastatic cervical cancer, offering a new option after ...
Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in a significant increase in survival rates, a new study shows.The ...
An HPV vaccine delivered into the nose can treat cervical tumors in mice. The vaccine targets a cancer protein produced by the virus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback